Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.
A Ylipää, K Kivinummi, A Kohvakka, M Annala… - Cancer …, 2015 - europepmc.org
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
[PDF][PDF] Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
A Ylipää, K Kivinummi, A Kohvakka, M Annala… - Cancer Res, 2015 - academia.edu
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
Transcriptome sequencing reveals PCAT5 as a Novel ERG-Regulated long Noncoding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka… - Cancer …, 2015 - mdanderson.elsevierpure.com
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
[PDF][PDF] Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long non-coding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka, M Annala… - Citeseer
Castration-resistant prostate cancer (CRPC) that arise after the failure of androgen blocking
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
[PDF][PDF] Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long non-coding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka, M Annala… - scholar.archive.org
Castration-resistant prostate cancer (CRPC) that arise after the failure of androgen blocking
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
[PDF][PDF] Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long non-coding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka, M Annala… - pdfs.semanticscholar.org
Castration-resistant prostate cancer (CRPC) that arise after the failure of androgen blocking
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
therapies cause most of the deaths from prostate cancer (PC), intensifying the need to fully …
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
A Ylipää, K Kivinummi, A Kohvakka… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
Transcriptome sequencing reveals PCAT5 as a Novel ERG-Regulated long Noncoding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka… - Cancer …, 2015 - researchportal.tuni.fi
Castration-resistant prostate cancers (CRPC) that arise after the failure of androgen-
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …
blocking therapies cause most of the deaths from prostate cancer, intensifying the need to …